*4.1.7 Chronic coronary syndrome*

Optimal adherence to guideline-directed medication therapy (i.e. a combination of antiplatelet drugs, ACEIs/ARBs, BBs, and statins) that reduced the risk of MACEs (HR 0.41, 95% CI 0.18–0.92, *P* = 0.03) was reported [55].
